Raymond James & Associates’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Raymond James & Associates’s Portfolio ZLTQ Stock Details ZLTQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-9,764	Closed	-$543K	–	3510
2017 Q1	$543K	Sell	9,764 -11,791	-55%	-$591K	﹤0.01%	2328
2016 Q4	$938K	Sell	21,555 -48	-0.2%	-$1.94K	﹤0.01%	1954
2016 Q3	$847K	Buy	21,603 +2,714	+14%	+$96.9K	﹤0.01%	1979
2016 Q2	$516K	Buy	18,889 +2,517	+15%	+$70.8K	﹤0.01%	2087
2016 Q1	$445K	Buy	+16,372	New	+$386K	﹤0.01%	2107
2015 Q4	–	Sell	-14,106	Closed	-$452K	–	2437
2015 Q3	$452K	Sell	14,106 -562	-4%	-$18.6K	﹤0.01%	1969
2015 Q2	$432K	Buy	14,668 +4,662	+47%	+$141K	﹤0.01%	2149
2015 Q1	$308K	Buy	+10,006	New	+$320K	﹤0.01%	2209

Other funds holding ZLTQ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Raymond James & Associates's ZLTQ Position: Q2 2017 in Review

Raymond James & Associates sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 9,764 shares — an estimated $543K sold.

Raymond James & Associates first reported a position in ZLTQ in Q1 2015 and held it in 8 quarters. The position peaked at $938K in Q4 2016. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.

Raymond James & Associates reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
Raymond James & Associates sold 9,764 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $543K.
Raymond James & Associates first reported a position in ZELTIQ Aesthetics, Inc. in Q1 2015 and held it in 8 quarters.
Raymond James & Associates's ZELTIQ Aesthetics, Inc. position peaked at $938K in Q4 2016.
2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.